Who the TSBP Regulates
Section summaryTSBP jurisdiction covers pharmacists, pharmacy technicians, pharmacy technician trainees, registered pharmacies (Class A retail, Class B nuclear, Class C institutional, Class D clinic, Class E non-resident), interns, and preceptors. Each licensee class has its own scope and discipline pathway.
The Texas Pharmacy Act defines several license types and registrant categories. The most common in disciplinary practice are Class A community pharmacies, Class C hospital and institutional pharmacies, and individual pharmacist and technician licensees.
Out-of-state mail-order pharmacies that ship into Texas are regulated as Class E pharmacies under §560.052. They are subject to the same disciplinary process as in-state pharmacies for conduct that touches Texas patients.
Disciplinary Grounds
Section summarySection 565.001 lists more than two dozen grounds for discipline. The most-common categories are unprofessional or dishonorable conduct, failure to follow recordkeeping requirements, drug diversion, dispensing without authority, impairment, and criminal conviction touching fitness to practice.
The statutory grounds at §565.001 (and corresponding Board rule chapter 281) drive most TSBP discipline. The catch-all "unprofessional conduct" captures behavior the Board considers below the professional standard even where a more specific provision does not apply.
Common complaint categories include:
- Dispensing errors. Wrong drug, wrong dose, wrong patient, wrong directions, or wrong label.
- Controlled-substance recordkeeping. Inventory reconciliation gaps, biennial inventory failures, DEA Form 222 issues.
- Diversion. Theft, self-dispensing, or assisting another in diversion.
- Practice without an active license. Lapsed license, no continuing education, or scope outside the licensee class.
- DUI or impairment. Substance use that compromises practice; PRN (Pharmacist Recovery Network) referral may be available.
- Criminal convictions. Felonies and certain misdemeanors touching the practice of pharmacy.
Audits and Investigations
Section summaryMost pharmacy discipline begins with an audit — by TSBP investigators, the DEA, the Texas Department of Public Safety Narcotics Division, or a payor. Audit findings get referred for investigative work-up and possible formal action.
Pharmacy inspections and audits under TSBP rule 291.17 are routine; a deficiency report triggers a follow-up timeline. Repeat or serious deficiencies escalate to formal complaints.
DEA audits address Controlled Substances Act compliance under 21 C.F.R. Part 1304. A DEA audit that uncovers significant recordkeeping problems can trigger parallel TSBP discipline based on the same facts; an Order to Show Cause from the DEA can also imperil the DEA registration that the pharmacy needs in order to dispense controlled substances at all.
Diversion and Theft Cases
Section summaryDiversion allegations against pharmacists run alongside criminal investigations. Coordinating the Board response with criminal counsel is essential to avoid statements that compromise the criminal case.
Diversion cases — where a pharmacist or technician is alleged to have taken controlled substances for personal use or for sale — are the highest-stakes pharmacy discipline. Texas Health & Safety Code Chapter 481 (the Texas Controlled Substances Act) provides parallel criminal liability, and federal law under 21 U.S.C. §841 reaches diversion.
A coordinated defense strategy considers:
- The Board's notice-of-investigation response and its potential criminal exposure.
- PRN (Pharmacist Recovery Network) referral as a mitigation pathway for impairment-based diversion.
- The DEA registration and whether it must be voluntarily surrendered or contested via OSC.
- Employer's separation and any associated payor or hospital privilege actions.
Compounding Violations
Section summaryUSP 797 (sterile compounding) and USP 800 (hazardous drug compounding) compliance is heavily inspected. Significant deviations that result in patient harm — or that demonstrate systematic departure from standards — drive formal action.
The Board's compounding rules (TSBP chapter 291, subchapter D, and the Texas-specific incorporations of USP 795/797/800) require strict environmental controls, beyond-use-date discipline, and quality-assurance documentation. Inspection findings most commonly involve:
- Beyond-use-date assignment without supporting stability data.
- Inadequate environmental monitoring (air sampling, surface sampling).
- Failure of master-batch records or compounding logs.
- Sterile-personnel competency lapses (gowning, hand hygiene, media-fill testing).
Where patient harm is alleged, the TSBP often coordinates with the Department of State Health Services and may refer to law enforcement in extreme cases. The 2012 New England Compounding Center cases set the modern enforcement tone for sterile-compounding failures nationwide.
Informal Settlement Conferences
Section summaryAs with most Texas licensing boards, the TSBP uses Informal Settlement Conferences (ISCs) to discuss allegations with the licensee, Board members, and Board staff. The ISC is the most common resolution path for cases the Board does not dismiss.
The ISC is the licensee's first meaningful opportunity to present the response to allegations face-to-face with two Board members and Board prosecutors. The outcome can be a dismissal, Remedial Plan, Agreed Order, or referral to formal proceedings.
Pharmacy ISCs often turn on remediation evidence: completed CE, PRN engagement, audit-finding correction, or recordkeeping system upgrades. The licensee's articulation of insight and corrective steps materially affects the proposed Agreed Order.
SOAH Practice for Pharmacy
Section summaryIf the ISC does not resolve the case, the Board files a formal complaint at SOAH for a contested case under the APA. The ALJ issues a Proposal for Decision; the Board issues the Final Order.
Pharmacy SOAH cases follow the standard Texas APA framework — formal complaint, answer, discovery, prehearing conference, hearing, PFD, exceptions, Final Order. The ALJ is independent of the Board and applies a preponderance-of-the-evidence standard.
Discovery in pharmacy SOAH cases commonly addresses the DEA Form 222 ledger, perpetual inventory records, dispensing software exports, compounding logs, and electronic prescription audit trails. Expert testimony from pharmacy practice experts is common where standard-of-practice is in dispute.
Sanctions and Reinstatement
Section summarySanctions range from administrative penalty and reprimand through restriction, probation, suspension, and revocation. Voluntary surrender resolves some cases but is reported as disciplinary action. Reinstatement after revocation requires a separate petition under Board rules.
The TSBP sanction range mirrors the broader pharmacy-discipline framework: reprimand, monetary penalty (capped by §566.052), restriction, probation with monitoring, suspension (active or stayed), and revocation. Voluntary surrender during the pendency of a case resolves the matter but is reported and may carry NABP and reciprocal-state consequences.
Reinstatement after revocation requires a formal petition, evidence of rehabilitation, and (frequently) PRN participation. Reinstatement is not guaranteed and the Board has broad discretion to deny or impose conditions.
Need defense counsel?
L&L Law Group, PLLC handles Professional License Defense cases throughout DFW. Initial consultations are free.
Call (972) 370-5060 →Investigation Procedure
Texas Pharmacy Board Discipline matters begin with a written complaint that the board's staff investigates. The licensee typically receives a notice of investigation that summarizes the allegation in general terms. The licensee has a finite window — often 20 to 30 days — to respond. For a TSBP matter, the response is the first strategic decision in the case and shapes the rest of the proceeding.
Counsel handling a TSBP matter should evaluate the strength of the underlying complaint, the agency's likely evidence, and the licensee's exposure across multiple sanction levels. The response can be comprehensive (admitting agreed facts, reserving contested issues, framing the licensee's narrative) or minimal (denying allegations broadly, reserving all issues for formal proceedings). Each approach has strategic advantages and costs.
The response should be coordinated with any parallel criminal case. Statements made to the board can become evidence in the criminal forum. Where the criminal case is active, the administrative response may need to be limited or to invoke the Fifth Amendment. The board can draw adverse inferences from privilege invocation in administrative proceedings; counsel must weigh whether the inference cost exceeds the criminal-exposure cost.
Sanction Continuum
Texas Pharmacy Board Discipline matters resolve across a sanction continuum from informal letter (the lightest, often non-public), through advisory letter, formal reprimand, fines, conditions on practice, suspension, and revocation. The right strategic target depends on the strength of the State's evidence, the licensee's history, and the agency's internal calibration.
For a TSBP matter, counsel should map the likely sanction range early and negotiate toward the best feasible outcome. Where the evidence is strong and a public sanction is unavoidable, counsel should focus on minimizing the sanction's severity and on shaping the public-record language. Where the evidence is contestable, counsel should consider whether contesting through SOAH produces a better expected outcome than accepting an Agreed Order.
The public-record consequences of any formal sanction are significant. Most Texas boards maintain searchable disciplinary databases that anyone can access. The record persists for the duration of the license and often beyond. Counsel should always discuss the public-record dimension with the client before recommending any disposition.
The Texas State Board of Pharmacy framework
The Texas State Board of Pharmacy operates under Texas Occupations Code Chapter 551 through 569 and Board Rules at 22 Texas Administrative Code Chapter 281. The Board regulates the practice of pharmacy in Texas including the licensure of pharmacists, pharmacy technicians, and pharmacies. The framework includes comprehensive disciplinary authority covering both clinical pharmacy practice and pharmacy operations.
The disciplinary grounds under the Pharmacy Act include unprofessional conduct, dispensing errors causing harm, controlled substance violations, fraudulent billing, drug diversion, and various other specific categories. The grounds reach both individual pharmacist conduct and pharmacy operational issues. The defense must address both the specific grounds and the broader pharmacy regulatory context.
The Board investigation framework operates through Board investigators and inspectors. The investigations include review of prescription records, interviews with pharmacists and pharmacy staff, examination of pharmacy facilities, evaluation of inventory and dispensing records, and consultation with pharmacy experts. The respondent has rights to notice and to participate in the investigation through counsel.
The dispensing error framework and the practice considerations
The dispensing error framework addresses errors in the dispensing of medications including wrong drug errors, wrong dose errors, wrong patient errors, and various other categories. The framework recognizes that the dispensing process involves multiple opportunities for error and includes both individual pharmacist responsibilities and pharmacy system considerations.
The root cause analysis framework helps identify the contributing factors to dispensing errors. The analysis can include factors such as workload, staffing, automation, processes, technology, and individual decision-making. The defense in dispensing error cases should examine the comprehensive factors that contributed to the specific error rather than focusing exclusively on individual pharmacist conduct.
The harm assessment in dispensing error cases addresses the consequences of the specific error. Errors that produced no harm may produce educational responses or minor sanctions. Errors that produced substantial harm or death produce more substantial disciplinary action. The defense should examine the specific harm and should develop arguments about the appropriate proportionate response.
The controlled substance framework and the Prescription Monitoring Program
The controlled substance framework in pharmacy practice involves both federal DEA requirements and state Pharmacy Act provisions. Pharmacists must maintain DEA registrations for controlled substance dispensing, maintain specific records, comply with reporting requirements, and various other specific obligations. Failures in controlled substance compliance can produce substantial disciplinary consequences and parallel criminal exposure.
The Texas Prescription Monitoring Program (PMP) tracks controlled substance dispensing and provides information to pharmacists and prescribers. The PMP framework includes specific consultation requirements before dispensing certain controlled substances. Failures to consult the PMP appropriately can produce disciplinary action. The defense should be familiar with the PMP framework and should examine pharmacy compliance practices.
The diversion cases reach conduct involving misappropriation of controlled substances by pharmacy staff. The cases can include theft of controlled substances from pharmacy inventory, fraudulent prescriptions filled by complicit pharmacists, and various other categories. The defense in diversion cases must coordinate the regulatory and criminal defenses with attention to the comprehensive implications.
Disposition framework and the practice continuity considerations
The disposition framework in pharmacy discipline cases includes various negotiated outcomes including remedial education requirements, practice restrictions, supervision arrangements, license suspensions, and license revocations. The disposition options should be evaluated against the realistic litigation outcomes and the comprehensive practice implications.
The practice continuity considerations include how disposition options affect the pharmacist ability to continue practice. License suspensions and substantial restrictions can effectively end practice during the relevant period. Other dispositions may have minimal practical impact. The defense should address these implications when evaluating disposition options.
The Texas Pharmacist Recovery Network provides a structured framework for pharmacists with substance abuse or mental health issues. Participation in TPRN can support favorable disposition in impairment cases. The defense should consider whether TPRN participation is appropriate for the specific case and should support pharmacists in engaging with the program when it provides a path to addressing underlying issues and resolving the disciplinary matter favorably.
Frequently Asked Questions
What triggers a TSBP audit?
Can a pharmacy technician have their registration revoked?
What is PRN (Pharmacist Recovery Network)?
Does a TSBP order affect other state pharmacy licenses?
Read the full Texas Professional License Defense Guide
This article is one section of our comprehensive Texas Professional License Defense Guide. The pillar guide covers recent developments, official resources, and the complete framework with deeper analysis.
Read the Pillar Guide →Next Steps
If you are facing a situation described here, consult counsel promptly. Many issues in this area run on strict deadlines.
- Call (972) 370-5060
- Email info@landllawgroup.com
Cite this guide
Bluebook: Reggie London & Njeri London, Texas Pharmacy Board Discipline, L&L Law Group (May 30, 2026), https://landllawgroup.com/insights/texas-pharmacy-board-discipline/.
APA: London, R., & London, N. (2026, May 30). Texas Pharmacy Board Discipline. L&L Law Group.